当前位置:首页 - 行情中心 - 海森药业(001367) - 财务分析 - 现金流量表

海森药业

(001367)

  

流通市值:32.22亿  总市值:40.36亿
流通股本:1.22亿   总股本:1.52亿

现金流量表

报告期2025-12-312025-09-302025-06-302025-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金394,681,831.03295,538,019.6201,941,423.47100,533,268.72
  收到的税费返还12,593,342.986,633,093.623,018,544.23690,127.28
  收到其他与经营活动有关的现金15,588,954.548,512,647.725,288,700.973,158,403.72
  经营活动现金流入小计422,864,128.55310,683,760.94210,248,668.67104,381,799.72
  购买商品、接受劳务支付的现金108,631,921.36104,370,799.0965,119,280.8826,014,736.8
  支付给职工以及为职工支付的现金80,588,504.9161,552,094.2243,101,401.826,122,347.43
  支付的各项税费21,525,818.4819,455,575.8717,262,659.148,153,945.73
  支付其他与经营活动有关的现金34,664,292.7818,101,074.5410,438,693.273,631,982.39
  经营活动现金流出小计245,410,537.53203,479,543.72135,922,035.0963,923,012.35
  经营活动产生的现金流量净额177,453,591.02107,204,217.2274,326,633.5840,458,787.37
二、投资活动产生的现金流量:
  收回投资收到的现金1,943,017,801.561,260,661,019.51338,568,726.3665,213,663.34
  投资活动现金流入小计1,943,017,801.561,260,661,019.51338,568,726.3665,213,663.34
  购建固定资产、无形资产和其他长期资产支付的现金152,263,155.87138,557,108.37122,116,302.5946,911,894.16
  投资支付的现金2,088,000,0001,748,000,000828,000,000235,000,000
  投资活动现金流出小计2,240,263,155.871,886,557,108.37950,116,302.59281,911,894.16
  投资活动产生的现金流量净额-297,245,354.31-625,896,088.86-611,547,576.23-216,698,230.82
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,580,726.83,580,726.8--
  筹资活动现金流入平衡项目00--
  筹资活动现金流入小计3,580,726.83,580,726.8--
  分配股利、利润或偿付利息支付的现金17,451,01017,451,01017,451,010-
  支付其他与筹资活动有关的现金1,723,765273,735--
  筹资活动现金流出平衡项目000-
  筹资活动现金流出小计19,174,77517,724,74517,451,010-
  筹资活动产生的现金流量净额平衡项目000-
  筹资活动产生的现金流量净额-15,594,048.2-14,144,018.2-17,451,010-
四、汇率变动对现金及现金等价物的影响912,993.881,242,771.261,166,299.42837,720.09
五、现金及现金等价物净增加额-134,472,817.61-531,593,118.58-553,505,653.23-175,401,723.36
  加:期初现金及现金等价物余额1,034,482,112.281,034,482,112.281,034,482,112.281,034,482,112.28
  期末现金及现金等价物余额900,009,294.67502,888,993.7480,976,459.05859,080,388.92
补充资料:
  净利润135,879,665.78-60,794,153.31-
  资产减值准备3,451,459.11-705,117.39-
  固定资产和投资性房地产折旧19,744,823.14-7,994,994.74-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧19,744,823.14-7,994,994.74-
  无形资产摊销2,310,675.37-900,732.96-
  长期待摊费用摊销468,106.08-228,858.13-
  固定资产报废损失400,279.01-204,663.86-
  公允价值变动损失-1,695,000---
  财务费用397,911.99--886,147.78-
  投资损失-5,017,801.56--568,726.36-
  递延所得税1,656,928.64--1,909,436.41-
  其中:递延所得税资产减少-565,390.76---
    递延所得税负债增加2,222,319.4--1,909,436.41-
  存货的减少-3,047,456.02-297,544.59-
  经营性应收项目的减少-16,481,382.23-7,486,547.03-
  经营性应付项目的增加17,169,393.06--1,513,438.19-
  其他20,711,020.83--161,862.15-
  现金的期末余额820,009,294.67-480,976,459.05-
  减:现金的期初余额1,034,482,112.28-1,034,482,112.28-
  加:现金等价物的期末余额80,000,000---
  现金及现金等价物的净增加额-134,472,817.61--553,505,653.23-
公告日期2026-03-262025-10-222025-08-152025-04-26
审计意见(境内)标准无保留意见
TOP↑